DPW
MYGN icon

DiNuzzo Private Wealth’s Myriad Genetics MYGN Stock Holding History

DiNuzzo Private Wealth’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-3
Closed -$42 – 1408
2024
Q4 		$42 Sell
3
-10
-77% -$185 ﹤0.01% 1380
2024
Q3 		$357 Buy
13
+6
+86% +$162 ﹤0.01% 1196
2024
Q2 		$172 Buy
7
+1
+17% +$22 ﹤0.01% 1286
2024
Q1 		$128 Sell
6
-1
-14% -$21 ﹤0.01% 1262
2023
Q4 		$134 Buy
+7
New +$121 ﹤0.01% 1283

Other funds holding MYGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

DiNuzzo Private Wealth's MYGN Position: Q1 2025 in Review

DiNuzzo Private Wealth sold out of Myriad Genetics (MYGN) in Q1 2025, closing a stake of 3 shares — an estimated $42 sold.

DiNuzzo Private Wealth first reported a position in MYGN in Q4 2023 and held it in 5 quarters. The position peaked at $357 in Q3 2024. 228 funds tracked by Wall St. Rank hold MYGN as of Q1 2025.

  • DiNuzzo Private Wealth reported no remaining Myriad Genetics position as of Q1 2025 after selling out during the quarter.
  • DiNuzzo Private Wealth sold 3 Myriad Genetics shares in Q1 2025, an estimated $42.
  • DiNuzzo Private Wealth first reported a position in Myriad Genetics in Q4 2023 and held it in 5 quarters.
  • DiNuzzo Private Wealth's Myriad Genetics position peaked at $357 in Q3 2024.
  • 228 funds tracked by Wall St. Rank held Myriad Genetics as of Q1 2025.

Based on DiNuzzo Private Wealth's 13F filing for Q1 2025, filed 25 Apr 2025.